🔬 Advanced Recombinant Humanized Collagen Technology
Skip to content
When we are young, skin collagen undergoes continuous synthesis and degradation, maintaining a dynamic equilibrium. As age advances, this balance shifts: new collagen synthesis slows, existing collagen degradation accelerates, and damaged collagen fibers are repaired less efficiently.
Thus, age-related collagen loss is not a sudden "disappearance" of collagen, but a gradual decline in the skin's biological capacity to maintain its structural collagen network.
This transformation begins primarily in the dermis. Dermal fibroblasts are responsible for synthesizing and maintaining collagen fibers, but their functional capacity diminishes significantly in aging skin. Transforming growth factor-beta (TGF-β) signaling—which regulates collagen synthesis—declines, while matrix metalloproteinase (MMP) activity continuously increases.
Consequently, collagen fibers undergo fragmentation, cleavage, and structural disorganization. Once the collagen matrix loses its structural integrity, fibroblasts can no longer maintain optimal mechanical tension, which further suppresses collagen synthesis in a self-reinforcing vicious cycle.
Chronological aging reduces collagen synthesis efficiency, while ultraviolet (UV) radiation accelerates its breakdown.
Chronic UV exposure increases reactive oxygen species (ROS), triggering the overexpression of MMPs. Although MMPs normally function to clear damaged extracellular matrix (ECM), sustained MMP elevation leads to the indiscriminate breakdown of healthy collagen fibers. Recent photoaging research consistently identifies elevated MMP activity as a key driver of aberrant collagen breakdown.
In an animal model of UV-induced photoaging, Jing Wang et al. observed a 41.5% decrease in skin collagen content following 8 weeks of UV exposure, accompanied by disorganized collagen fibers, reduced elasticity, and ECM damage. Interventions using recombinant humanized Type III collagen demonstrated notable improvements in Type I and Type III collagen markers, skin elasticity, and overall tissue architecture. This study illustrates that photoaging-induced collagen loss involves not merely quantitative reduction, but profound alterations in collagen structure and the surrounding metabolic microenvironment.
Concurrently, the superficial skin layers undergo aging. In a review on epidermal and dermal aging, Taihao Quan highlighted that Type XVII collagen expression is vulnerable to both chronological aging and UV damage. As Type XVII collagen degrades, the anchorage between epidermal basal cells and the basement membrane weakens, leading to epidermal thinning and destabilization of the dermal-epidermal junction (DEJ).
This explains why age-related skin changes are rarely isolated issues. Dryness, roughness, fine lines, loss of elasticity, sagging, and compromised facial contours are collectively driven by decreased collagen synthesis, accelerated degradation, and weakened inter-layer structural connections.
Collagen depletion manifests differently across life stages. Around age 30, fine lines typically emerge first in high-expression areas such as the periocular region, glabella, and forehead. In mature skin, structural concerns expand to include loss of elasticity, facial sagging, compromised barrier function, and multi-zone deep wrinkles.
Rather than applying a one-size-fits-all collagen formula, ProtYouth designs targeted product architectures aligned with specific stages of collagen loss.
To address early localized expression lines, ProtYouth T16 Single-Ingredient Collagen Ampoule features an engineered structure where the core functional domain of Type III collagen is tandem-repeated 16 times, delivering 2 mg of recombinant collagen per single-dose ampoule.In a 28-day clinical evaluation involving 31 women aged 39–55:
The formulation logic of T16 centers on high-density repetition of Type III collagen’s cell-adhesion domain, providing concentrated intervention for early ocular and expression lines.
When collagen depletion progresses to multi-zone wrinkles, loss of firmness, and sagging, ProtYouth Triple Collagen Cream utilizes a synergized blend of Recombinant Type III, Type VII, and Type XVII Collagens:
In a 28-day clinical evaluation involving 31 women with sensitive skin aged 39–55:
These formulations align with distinct physiological needs: T16 offers focused precision for early localized expression lines, while Triple Collagen Cream delivers multi-dimensional support for complex elasticity, firmness, barrier, and deep-wrinkle concerns in mature skin.
Ultimately, collagen depletion occurs because skin collagen synthesis slows down while breakdown accelerates.
Diminished fibroblast activity hinders new collagen formation, while elevated MMP levels and oxidative stress persistently degrade existing fibers. As distinct collagen types (Type III, VII, XVII) undergo structural decline, skin manifests visible fine lines, sagging, loss of contour definition, and barrier dysfunction.
ProtYouth designs collagen skincare from this stage-specific, multi-structural perspective. T16 delivers targeted care for early localized lines, while Triple Collagen Cream combines three recombinant collagens to meet the comprehensive age-defying needs of mature skin.
While time cannot be paused, collagen depletion is not a process to accept passively. Understanding the mechanisms behind collagen loss empowers individuals to choose precise, scientifically aligned collagen skincare for their skin's specific stage.
Why Does Collagen Deplete as We Age? It Is More Than Just "Decreased Production"